Skip to Main Content

User Profile

AGLN - Aspen Global Leadership Network
  • About AGLN
    Mission, Approach, Impact Leadership and Team AGLN Moderators Blog
  • Fellowships
    ABOUT
    AGLN Fellowships Becoming a Fellow Lifelong Engagement Search the AGLN Directory
    US-BASED FELLOWSHIPS
    Civil Society Fellowship Health Innovators Fellowship Henry Crown Fellowship Liberty Fellowship Pahara Fellowship
    GLOBAL FELLOWSHIPS
    Africa Leadership Initiative - East Africa Africa Leadership Initiative - South Africa Africa Leadership Initiative - West Africa Finance Leaders Fellowship Central America Leadership Initiative China Fellowship Program Kamalnayan Bajaj Fellowship Middle East Leadership Initiative
  • Ventures
  • Action Forum
    About Register Previous Action Forums 2024 Action Forum Recap Youth Action Forum Partners & Supporters
  • Login
Greg Yap
Greg Yap

Greg Yap

Connect on Social Media

[Edit]

LinkedIn:
linkedin.com/in/yapgreg/
Twitter:
twitter.com/grgyap
Facebook:
facebook.com/greg.yap.10

About

[Edit]

First Name:
Greg
Last Name:
Yap
Title and Organization:
Partner, Menlo Ventures
Bio:
Greg Yap, MBA, is a partner at Menlo Ventures, where he invests in teams trying to solve major problems in life science and healthcare, with a special interest in novel therapeutic platforms, patient-focused digital health, and transformative technologies. Previously, Greg was an entrepreneur-in-residence at Illumina Ventures, where he focused on new investments related to genomics. Prior to entering venture capital, Greg had 20 years of experience in senior executive and entrepreneurial roles in life science and digital health. He was CEO and co-founder of two startups: Biodesy, a next generation protein analysis company, and PyrAmes, a digital health remote monitoring company. At Roche Diagnostics/Ventana, Greg led a global market-leading cancer diagnostic assay business, serving 20 million patients and delivering $500 million revenue per year. Greg’s operating experience also includes roles as the first healthcare entrepreneur-in-residence at GE; chief operating officer at Cellpoint Diagnostics, an early liquid biopsy startup; vice president and general manager for genetics and molecular diagnostics at Affymetrix, the microarray genomics pioneer; and consultant for McKinsey & Company. He also serves on the board of Outward Bound California. Greg received his bachelor’s degree in molecular biology (summa cum laude) from Princeton University and his MBA from Stanford University’s Graduate School of Business. Greg’s current investments include Clear Labs, Encoded Therapeutics, Epiodyne, Pliant Therapeutics, Sana Health, and Senti Bio. He is a San Francisco Bay Area native and lives in Palo Alto, CA, with his wife and children. Greg is a Fellow of the fifth class of the Health Innovators Fellowship and a member of the Aspen Global Leadership Network.

Fellowship Program

[Edit]

Program Membership:
Health Innovators Fellowship

Class

[Edit]

Fellowship Class Name:
Class V: High Five


© The Aspen Institute | Privacy Policy | Terms of Use | Powered by Personify Community
Facebook Twitter YouTube Instagram

You are here because you are logging into the AGLN community website for the first time or you forgot your password.

 

Please enter the email address associated with your account and a new password will be sent to you. If you are still having issues logging in or do not have access to the email that the Aspen Global Leadership Network uses to contact you, please email agln.info@aspeninstitute.org to have your password manually reset and sent to you.